Clinical Trial Update: L-PZQ ODT in Schistosoma Infected Children [Phase 3]

View source ↗

Summary

Phase 3 trial update for L-PZQ ODT in children infected with schistosomiasis; study completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• L-PZQ ODT (piperazine-like suspension? (L-PZQ stands for L-praziquantel) or null)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Schistosomiasis | Phase 3 | Status: COMPLETED | Results posted: 2024-03-21